Skip to nav Skip to content

Graphic for MLL meetingsThe Machine Learning League (MLL) objective at Moffitt Cancer Center is to advance awareness and application of Machine Learning, Deep Learning, and Artificial Intelligence (AI) across the multiple disciplines in cancer research. This will be achieved by sharing the latest advancements in the field and brainstorming on how they could be applied to solving the cancer problem. In addition, there will be educational sessions on new tools and technologies that are used in machine learning applications.

League events will include guest lectures, presentations and tutorials, as well as, software tools, packages, and libraries.

The Machine Learning League meetings are held internally typically every other Thursday at noon EST. This is an open invitation to anyone who is interested or wishes to participate in learning and understanding about topics related to machine learning.

Date  Presenter Topic Details Watch Now
Jan. 17, 2024 Manh-Huong Phan Opportunities in Nanobiomagnetism and Healthcare Monitoring Materials science is considered the backbone of modern technologies. Materials are key components in many electronic devices. Nanomaterials with superparamagnetic properties are promising candidates for biomedical applications ranging from hyperthermia therapy to targeted drug delivery, magnetic resonance imaging and biodetection. In this lecture, I will discuss emerging opportunities and technical challenges in this interdisciplinary research field, as well as propose new strategies to overcome the challenges. I will also highlight recent development of a novel, non-invasive, and contactless magnetic sensing platform for real-time tracking and diagnosis of COVID-19 and other respiratory-associated diseases by harnessing magnetism and machine learning. Our technology can be deployed in healthcare facilities and community settings for onsite and remote patient monitoring, which has the potential to improve the overall healthcare system and facilitate more effective public health measures to curb the spread of COVID-19 and its variants.   View recording 
Jan. 29, 2024 Prof. Nagarajan Vaidehi   Spatiotemporal Determinants and Allosteric Communication Modulate the Ligand Bias in GPCRs   G-protein coupled receptors (GPCRs) form the largest superfamily of drug targets and also play a critical role in cell signaling. The interactions of GPCRs with the G proteins or b-arrestins to propagate a signaling pathway are inherently often transient and dynamic. However, these interactions exhibit exquisite level of selectivity in some cases or promiscuity in other cases, in coupling to one or multiple partner proteins upon a cell signaling event. Using multi-scale molecular dynamics simulations, allosteric communication methods and interpretable machine learning Bayesian network models in combination with FRET experiments and cell-based assays we have shown that the spatio-temporal components play a critical role in explaining the selective coupling of GPCRs towards G proteins and b-arrestins. We have identified residue pairs that show high cooperativity and their allosteric effect in the GPCR:G protein interface.  Our results reveal a strong co-dependency in the formation of interface GPCR:G protein contacts. The MD simulations show that reshaping of GPCR-G protein coupling interface explains the promiscuous coupling of some GPCRs to multiple G proteins. Allosteric communication in signaling proteins play an important role in transducing signal across cell membranes and allosteric modulators are much sought after therapeutics. Delineating the amino acid residues involved in this communication network would allow us to design allosteric ligands that can modulate the potency and efficacy of the orthosteric ligands. Here we show a pathway to identify cryptic druggable binding sites in GPCRs that can be used to identify allosteric ligands.

View recording 

March 6, 2024 Hassan Fathallah-Shaykh Volumetrics in Glioma: A New Standard The RANO criteria define the current standard of care for longitudinal monitoring of gliomas. I will discuss recent findings that compare volumetric longitudinal measurements to visual inspection and the RANO criteria. I will also present data on AI-facilitated measurements for gliomas.  

View recording

March 26, 2024 Raymond Norris Parallel Computing with MATLAB for Moffitt Cancer Center Using the Parallel Computing capabilities in MATLAB allows users to take advantage of additional hardware resources that may be available either locally on their desktop or on clusters, clouds, and grids. By using more hardware, you can reduce the cycle time for your workflow and solve computationally and data-intensive problems faster. In this seminar, we discuss a range of workflows available to scale MATLAB applications with minimal changes to your MATLAB code and without needing to learn low-level programming. We’ll also demonstrate how to submit jobs to Moffitt’s HPC cluster, RED, from MATLAB.

View recording

March 27, 2024 Dr. Reza Fazel-Rezai Medical Image Processing and Machine Learning Workflow Medical images are obtained from various sources including MRI, CT, X-ray, ultrasound, and PET scans. Analyzing these images necessitates a comprehensive environment for data access, visualization, processing, and algorithm development. A key challenge involves extracting quantitative features to generate clinically relevant information using advanced techniques like machine learning algorithms. These features quantify shape, intensity, and texture characteristics within medical images, reducing reliance on subjective interpretation for clinical workflows. During this presentation, we will discuss how MATLAB facilitates those actions for medical images and explore radiomics which captures characteristics not typically visible.

View recording


May 13, 2024 Heather Whitney

AI of Medical Imaging for Clinical Translation of Radiomics

Computer-aided diagnosis (CAD) uses artificial intelligence and machine learning (AI/ML) methods to analyze medical images at scale and provide clinical decision-making support. Using ‘big data’ in CAD across the pipeline enhances the potential for impactful clinical tools while also requiring careful attention to the quality of the data. Subsequently, evaluating CAD across the AI/ML pipeline, including at the patient level, is essential for clinical translation. In this talk, I will discuss the need for data in AI development and the role of the Medical Imaging and Data Resource Center ( I will also discuss recent projects in advancing methods to evaluate computer output of likelihood of cancer at the patient level, for breast cancer using dynamic contrast-enhanced magnetic resonance imaging.


View recording

May 29, 2024 Svitlana Volkova

Harnessing the Power of Specialized Compound AI Systems for Breakthroughs in Biomedical Research and Beyond

The landscape of artificial intelligence is rapidly evolving, with the emergence of domain-specific compound AI systems that combine deep specialized knowledge with broad general intelligence. In this talk, we will explore the potential of specialized compound AI systems to revolutionize biomedical research and enable groundbreaking discoveries, while emphasizing the importance of user-centric AI development, human-AI teaming, and the safety and trustworthiness of AI systems.

Awaiting presentation

If you are interested in joining the Machine Learning League distribution list or have any other questions, concerns, or even suggestions please contact Machine Learning at